International Journal of Oncology

Disruption of functions of wild-type p53 by hetero-oligomerization.
pp. 413-435(23)
Authors: Deb; Chakraborti; Lányi; Troyer; Deb

Amplification of telomeric DNA directly correlates with metastatic potential of human and murine cancers of various histological origin.
pp. 423-432(10)
Authors: Multani, A S; Ozen, M; Sen, S; Mandal, A K; Price, J E; Fan, D; Radinsky, R; Ali-Osman, F; Von Eschenbach, A C; Fidler, I J; Pathak, S

Expression of keratinocyte growth factor receptor compared with that of epidermal growth factor receptor and erbB-2 in endometrial adenocarcinoma.
pp. 431-436(6)
Authors: Visco, V; Carico, E; Marchese, C; Torrisi, M R; Frati, L; Vecchione, A; Muraro, R

Modulation of integrin expression on mesotheliomas: the role of different histotypes in invasiveness.
pp. 437-479(43)
Authors: Giuffrida, A; Vianale, G; Di Muzio, M; Pass, H I; Coletti, A; Birarelli, P; Procopio, A; Modesti, A

Identification of a 5-cM region of common allelic loss on 8p12-p21 in human breast cancer and genomic analysis of the hEXT1L/EXTR1/EXTL3 gene in this locus.
pp. 443-494(52)
Authors: Suzuki, A; Shao, X; Song, X Q; Hanaoka, T; Irie, S; Kashiwada, M; Samara, G; Close, L G; Aoki, T; Fujimori, M; Ishikawa, Y; Hatori, M; Hosaka, M; Sakurada, A; Sato, M; Ohuchi, N; Satomi, S; Fukushige, S; Horii, A; Sato, T

Stromal expression of thrombospondin-1 is correlated with growth and metastasis of human gallbladder carcinoma.
pp. 453-460(8)
Authors: Ohtani, Y; Kijima, H; Dowaki, S; Kashiwagi, H; Tobita, K; Tsukui, M; Tanaka, Y; Tsuchida, T; Tokunaga, T; Yamazaki, H; Nakamura, M; Ueyama, Y; Tanaka, M; Tajima, T; Makuuchi, H

Genomic alterations in human meningiomas detected by restriction landmark genomic scanning and immunohistochemical studies.
pp. 459-525(67)
Authors: Inui, T; Konishi, N; Nakamura, M; Cho, M; Naitou, H; Yamamoto, K; Tsuzuki, T; Kawai, S; Tsunoda, S; Sakaki, T; Hiasa, Y

Radiotherapy for large hepatocellular carcinoma combined with transcatheter arterial embolization and percutaneous ethanol injection therapy.
pp. 467-540(74)
Authors: Yasuda, S; Ito, H; Yoshikawa, M; Shinozaki, M; Goto, N; Fujimoto, H; Nasu, K; Uno, T; Itami, J; Isobe, K; Shigematsu, N; Ebara, M; Saisho, H

Importance of the level of axillary involvement in relation to traditional variables in the prognosis of breast cancer.
pp. 475-555(81)
Authors: Zurrida, S; Morabito, A; Galimberti, V; Luini, A; Greco, M; Bartoli, C; Raselli, R; Rossi, N; Vessecchia, G; Cascinelli, N; Veronesi, U

Receptor for interleukin 13 is abundantly and specifically over-expressed in patients with glioblastoma multiforme.
pp. 481-487(7)
Authors: Debinski, W; Gibo, D M; Slagle, B; Powers, S K; Gillespie, G Y

Mouse leukemia L1210 cells selected for resistance to the ribonucleotide reductase inhibitor, 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone show altered response to DNA damaging agents.
pp. 487-577(91)
Authors: Crenshaw, T R; Cory, J G

p53 point mutation and survival in colorectal cancer patients: effect of disease dissemination and tumour location.
pp. 491-499(9)
Authors: Goh, H S; Elnatan, J; Low, C H; Smith, D R

Induction of apoptosis by N-(4-hydroxyphenyl)retinamide in glioma cells.
pp. 499-1003(505)
Authors: Saitoh, Y; Goto, T; Puduvalli, V K; Murakami, M; Kochi, M; Levin, V A; Kyritsis, A P; Ushio, Y

Subsequential telomerase activity in exfoliated urinary cells detects recurrent disease in bladder cancer after transurethral resection.
pp. 505-515(11)
Authors: Kitsukawa, S I; Ohyashiki, K; Yahata, N; Ebihara, Y; Aizawa, T; Ito, T; Miki, M

Production of ex vivo expanded hematopoietic cells and progenitors in a closed bioreactor, starting with a small volume marrow collection: A feasibility study in patients with poor-risk breast cancer and receiving high-doses of cyclophosphamide.
pp. 511-519(9)
Authors: Chabannon, C; Blache, J L; Sielleur, I; Douville, J; Faucher, C; Gravis, G; Arnoulet, C; Oziel-Taieb, S; Blaise, D; Novakovitch, G; Camerlo, J; Chabbert, I; Genre, D; Appel, M; Armstrong, D; Maraninchi, D; Viens, P

The mitogen activated protein kinase pathway is required for proliferation but not invasion of human squamous cell carcinoma lines.
pp. 519-542(24)
Authors: Tsang, D K; Crowe, D L

Induction of apoptosis and inhibition of c-erbB-2 in MDA-MB-435 cells by genistein.
pp. 525-558(34)
Authors: Li, Y; Bhuiyan, M; Sarkar, F H

Ceramide toxicity and metabolism differ in wild-type and multidrug-resistant cancer cells.
pp. 535-575(41)
Authors: Lucci, A; Giuliano, A E; Han, T Y; Dinur, T; Liu, Y Y; Senchenkov, A; Cabot, M C

Modification of ceramide metabolism increases cancer cell sensitivity to cytotoxics.
pp. 541-547(7)
Authors: Lucci, A; Han, T Y; Liu, Y Y; Giuliano, A E; Cabot, M C

Tumor suppressor gene alterations in malignant gliomas: histopathological associations and prognostic evaluation.
pp. 547-600(54)
Authors: James, C D; Galanis, E; Frederick, L; Kimmel, D W; Cunningham, J M; Atherton-Skaff, P J; O'Fallon, J R; Jenkins, R B; Buckner, J C; Hunter, S B; Olson, J J; Scheithauer, B W

Frequency and pattern of p53 gene mutation in a cohort of Spanish women with node-negative breast cancer.
pp. 555-563(9)
Authors: Meng, L; Lin, L; Fresno, M; Morales, A R; Nadji, M

Overexpression of multidrug resistance genes MDR1 and cMOAT in human hepatocellular carcinoma and hepatoblastoma cell lines.
pp. 559-622(64)
Authors: Minemura, M; Tanimura, H; Tabor, E

Suppression of rat liver tumorigenesis by 25-hydroxycholesterol and all-trans retinoic acid: differentiation therapy for hepatocellular carcinoma.
pp. 565-574(10)
Authors: Yokoyama, S; Nozawa, F; Mugita, N; Ogawa, M

Use of the anionic dye carboxy-2',7'-dichlorofluorescein for sensitive flow cytometric detection of multidrug resistance-associated protein activity.
pp. 571-577(7)
Authors: Laupeze, B; Amiot, L; Courtois, A; Vernhet, L; Drenou, B; Fauchet, R; Fardel, O

Determination of telomerase activity in multifocal renal cell carcinoma.
pp. 577-658(82)
Authors: Schlichter, A; Fiedler, W; Junker, K; Dahse, R; Claussen, U; Schubert, J

Induction of apoptosis and inhibition of cellular proliferation as a dual approach to treatment of ovarian cancer.
pp. 583-591(9)
Authors: Edwards, J; Bartlett, J M

Inhibition of insulin-like growth factor I receptor signaling by the vitamin D analogue EB1089 in MCF-7 breast cancer cells: A role for insulin-like growth factor binding proteins.
pp. 589-683(95)
Authors: Rozen, F; Pollak, M

Angiogenesis is prognostically important in vertical growth phase melanomas.
pp. 595-604(10)
Authors: Straume, O; Salvesen, H B; Akslen, L A